Plerixafor Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Mar 13, 2026 · last update Mar 13, 2026
Manufacturers: Fresenius Kabi USA, LLC
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12) | Fresenius Kabi USA, LLC | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Mar 13, 2026 Updated Mar 13, 2026 Discontinued Mar 13, 2026 |